Announcement

Collapse
No announcement yet.

stem cell congress

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • stem cell congress

    REGISTER BY OCTOBER 30 AND SAVE UP TO $350!
    Plus, qualify for a 23andMe Custom Genome Scan.

    Cambridge Healthtech Institute's


    Track 3 at CHI's
    Molecular Medicine
    Tri-Conference

    View the agenda

    TheStemCellsCongress.com
    Pre-Conference Short Course*
    Tuesday, February 24, 2009

    CURRENT COMMERCIAL CONSIDERATIONS
    FOR CELL-BASED THERAPIES

    This course will review key considerations,
    strategies, and pivotal tactics for companies
    commercializing cell therapeutics and/or
    products that will be employed in that market.
    This course will be primarily designed for
    corporate executives, entrepreneurs, and
    investors.
    Topics to be covered:
    - An overview of the (current) cell therapy,
    regenerative medicine, and cells-as-tools
    market

    - Developing and implementing a clinical
    development strategy that positions a
    product for optimal reimbursement at or
    near the time of product launch

    - A review of key challenges facing the
    industry and how they will/must be
    addressed

    - A perspective on the role of various
    industry stakeholders including device,
    platform, reagent, investment, service,
    insurers, clinicians, and therapeutic
    companies.
    Course Instructors:
    Lee Buckler, Bed, LLB, Principal, Cell Therapy
    Group

    Dawn Driscoll, Ph.D, M.B.A., Principal,
    DCi Biotech


    For sponsorship and exhibit
    opportunities, contact
    Carol Dinerstein
    781-972-5471
    dinerstein@healthtech.comJon Stroup
    781-972-5483
    jstroup@healthtech.com


    Click here for details

    Address the topics central to the theme of regenerative medicine

    Network with prominent researchers, clinicians, businessmen and regulators at the
    cutting edge of their respective fields

    Develop strategies to enable the rapidly expanding therapeutic potential of
    regenerative medicine

    SESSION TOPICS INCLUDE - View agenda

    - The Stem Cell Niche
    - Controlling and Understanding Differentiation
    - Therapeutic Themes: Considerations for Cardia Regeneration
    - Harnessing Cells For Regenerative Healing
    - Therapeutic Themes: iPS Cells and Personalized Medicine
    New! Venture Capital and Emerging Company Forum




    Scientific Advisory Committee
    - Lee Buckler, LLB, Business Development, Progenitor Cell Therapy

    - Robert Deans, Ph.D., Senior Vice President, Regenerative Medicine, Athersys, Inc.

    - Rosemarie Hunziker, Ph.D., Program Director, Tissue Engineering & Regenerative
    Medicine, NIH/NIBIB

    - Mark E. Levenstein, Ph.D., Senior Scientist, CDI Biosciences

    - Patricia Olson, Ph.D., Senior Research Scientist, California Institute of Regenerative
    Medicine

    - Deepak Srivastava, M.D., Gladstone Institute of Cardiovascular Disease, University
    of California San Francisco


    Co-Sponsors
    Jake's Pop
Working...
X